Pharma Mar | PHM - Umlaufvermögen

Aktienkurs
86.65
Täglich Wechseln
3.40 4.08%
Monatlich
8.18%
Jährlich
-3.45%
Q1 Prognose
80.84




Umlaufvermögen Veränderung Datum
Akebia Therapeutics USD 252.96M 5.38M 2025-12
Alaunos Therapeutics USD 2.68M 1.05M 2025-09
Almirall EUR 713.98M 69K 2025-12
Avita Medical AUD 35.49M 760K 2025-12
Dianthus Therapeutics USD 409.44M 4.39M 2025-12
Ionis Pharmaceuticals USD 2.99B 471.01M 2025-12
IQVIA Holdings USD 6.25B 270M 2025-12
Laboratorios Farma EUR 509.33M 128.63M 2023-12
Moderna USD 6.54B 54M 2025-12
Organon & Co USD 4.7B 82M 2025-09
Pharma Mar EUR 283.41M 40.53M 2025-12
Revvity USD 2.24B 95.96M 2025-12
Tectonic Therapeutic USD 257.36M 15.88M 2025-12
Viatris USD 9.79B 162.2M 2025-12
Xeris Pharmaceuticals USD 240.31M 16.3M 2025-12